|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | |||||||||
| Prepaid assets and other current assets | |||||||||
| Total current assets | |||||||||
| Deferred offering costs | |||||||||
| Deferred offering costs and other assets | |||||||||
| Total assets | |||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||
| Current liabilities: | |||||||||
| Accounts payable | |||||||||
| Other accrued expenses | |||||||||
| Related party convertible notes payable at fair value | |||||||||
| Accrued compensation | |||||||||
| Accrued interest, current | |||||||||
| Total current liabilities | |||||||||
| Long term liabilities: | |||||||||
| Warrant liability | |||||||||
| Accrued interest, less current portion | |||||||||
| License payable | |||||||||
| Total long-term liabilities | |||||||||
| Total liabilities | |||||||||
| Redeemable convertible preferred stock, $0.000001 par value; no shares authorized, issued or outstanding at December 31, 2024; 33,463,018 shares authorized and 24,678,355 shares issued and outstanding at December 31, 2023; aggregate liquidation value of $0 and $121,033,336 as of December 31, 2024 and 2023, respectively | |||||||||
| Stockholders’ equity: | |||||||||
| Preferred stock, $0.000001 par value, 10,000,000 shares authorized, no shares issued or outstanding | |||||||||
| Common stock, $0.000001 par value, 200,000,000 shares authorized, 24,013,577 and 23,245,203 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated deficit | |||||||||
| Total stockholders’ equity | |||||||||
| Total liabilities and stockholders’ equity |
Loading...
